ADIPOQ and COVID-19: The existing data on adiponectin as a diagnostic or prognostic marker in COVID-19 has been inconsistent, often limited by small cohort sizes or confounding factors unrelated to COVID-19, such as BMI (Grewal and Buechler, 2023).